Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma

被引:23
|
作者
Shiba, Hiroaki [1 ]
Ishida, Yuichi [1 ]
Wakiyama, Shigeki [1 ]
Sakamoto, Taro [1 ]
Misawa, Takeyuki [1 ]
Yanaga, Katsuhiko [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
来源
CANCER SCIENCE | 2008年 / 99卷 / 10期
关键词
D O I
10.1111/j.1349-7006.2008.00958.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 77-year-old-man was admitted to hospital for treatment of a huge hepatocellular carcinoma by transarterial chemoembolization. After treatment, the patient developed acute tumor lysis syndrome with hyperkalemia, hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis and acute renal failure, which was successfully treated. In the treatments of solid organ tumors, acute tumor lysis syndrome is an extremely rare complication. To the best of the authors' knowledge, this patient is the third case of such a complication after transarterial chemoembolization for a hepatocellular carcinoma in the English literature. (Cancer Sci 2008; 99: 2104-2105)
引用
收藏
页码:2104 / 2105
页数:2
相关论文
共 50 条
  • [21] Transarterial chemoembolization for hepatocellular carcinoma
    Lau, WY
    Yu, SCH
    Lai, ECH
    Leung, TWT
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) : 155 - 168
  • [22] TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Vremera, Teodora
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (01): : 182 - 182
  • [23] Fever is not good after transarterial chemoembolization for hepatocellular carcinoma
    Yang, Hung-Chih
    ADVANCES IN DIGESTIVE MEDICINE, 2020, 7 (02) : 56 - 57
  • [24] PLEURITIS AND EMPYEMA AFTER TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA
    Channick, Jessica E.
    Brownstein, Adam J.
    Wilcox, Chad S.
    Zhong, Jin
    Hoo, Guy W. Soo
    CHEST, 2022, 162 (04) : 1391A - 1392A
  • [25] Hepatic Decompensation After Transarterial Chemoembolization For Hepatocellular Carcinoma
    Hughes, Dempsey
    Gordon, Fredric D.
    Stuart, Keith E.
    Nugent, F. W.
    Flake, Sebastian
    Simpson, Mary Ann
    Qamar, Amir A.
    HEPATOLOGY, 2015, 62 : 417A - 418A
  • [26] A rare complication after transarterial chemoembolization for hepatocellular carcinoma
    Huang, Y. -S.
    Chang, C. -C.
    Chang, Y. -C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (06) : 487 - 488
  • [27] Response to "Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma"
    Zhu, AX
    ONCOLOGIST, 2006, 11 (01): : 89 - 89
  • [28] Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma
    Woo, Hyun Young
    Jang, Jeong Won
    Choi, Jong Young
    Bae, Si Hyun
    You, Chan Ran
    Rha, Sung Eun
    Lee, Young Jun
    Yoon, Seung Kew
    Lee, Chang Don
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (03) : 332 - 339
  • [29] Correlation between Tumor Perfusion and Lipiodol Deposition in Hepatocellular Carcinoma after Transarterial Chemoembolization
    Yang, Lin
    Zhang, Xiao Ming
    Zhou, Xiang Ping
    Tang, Wei
    Guan, Yong Song
    Zhai, Zhao Hua
    Dong, Guo Li
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 21 (12) : 1841 - 1846
  • [30] Tumor lysis syndrome after treatment with sorafenib for hepatocellular carcinoma
    Kudo, Chieko
    Miura, Masahito
    Gamoh, Makio
    Niitani, Tomohito
    Tamagawa, Hiroki
    Takahashi, Kiichi
    Ichikawa, Sonoko
    Sugiyama, Katsuo
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2015, 4 (03): : 147 - 150